Crawford Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,137
Closed -$1.19M 263
2018
Q2
$1.19M Sell
7,137
-1,202
-14% -$193K 0.04% 157
2018
Q1
$1.4M Buy
+8,339
New +$1.4M 0.04% 152

Other funds holding AGN

Crawford Investment Counsel's AGN Position: Q3 2018 in Review

Crawford Investment Counsel sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 7,137 shares — an estimated $1.19M sold.

Crawford Investment Counsel first reported a position in AGN in Q1 2018 and held it in 2 quarters. The position peaked at $1.4M in Q1 2018. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Crawford Investment Counsel reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Crawford Investment Counsel sold 7,137 Allergan plc shares in Q3 2018, an estimated $1.19M.
  • Crawford Investment Counsel first reported a position in Allergan plc in Q1 2018 and held it in 2 quarters.
  • Crawford Investment Counsel's Allergan plc position peaked at $1.4M in Q1 2018.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Crawford Investment Counsel's 13F filing for Q3 2018, filed 9 Nov 2018.